Froylan Portillo retweetledi

#EuroPCR 2024 Major LBT – LANDMARK
Previous head-to-head comparisons of new THVs with established devices confirmed no class effect of clinical benefits after #TAVI with inferior safety & efficacy for some of them.
Validation of MyVal non-inferiority to the most widely used balloon-expandable and self-expandable platforms is therefore significant.
English











































